journal article·2023-11Open access

Ultra‐Bright Heptamethine Dye Clusters Based on a Self‐Adaptive Co‐Assembly Strategy for NIR‐IIb Biomedical Imaging

Zetao Dang, Xiangping Liu, Yijing Du, Yajun Wang, Ding Zhou, Yuewei Zhang, Shoujun Zhu

Advanced Materials· Volume 35· Issue 46

Abstract

Abstract Despite the wide range of applications of bright NIR‐II polymethine scaffolds in biomedical imaging, their solvatochromism and aggregation‐caused quenching (ACQ) effects in aqueous solutions limit their inherent brightness using traditional encapsulation methods, and effective hydrophilization strategies are still scarce. Here, a new set of Flav dyes is synthesized and PEGylated, followed by manufacturing DSPE@FlavP2000 nanoparticles using a self‐adaptive co‐assembly strategy to overcome these limitations. FlavP2000 can autonomously adjust its conformation when co‐assembled with DSPE‐PEG2000, resulting in high‐efficiency luminescence (≈44.9% fluorescence of Flav in DMSO). DSPE@FlavP2000 enables NIR‐IIb (>1500 nm) angiography with high signal‐to‐noise ratios. Notably, this co‐assembly can occur in situ between FlavP2000 with proteins in the living body based on a novel mechanism of brightness activation induced by disassembly (BAD), achieving consistent brightness as DSPE@FlavP2000 in blood or serum. The self‐adaptive co‐assembly strategy can be enhanced by incorporating an IPA moiety, which dynamically binds to albumin to prolong the dye's blood circulation time. Thus, the “enhanced” BAD is successfully applied to long‐term vascular imaging and sciatic nerve imaging. Both the self‐adaptive co‐assembly strategy and BAD phenomenon improve the selectivity and availability of the hydrophilization methods, paving the way for efficient biological applications of polymethine dyes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Supramolecular Structure and Materials Center for Supramolecular Chemical Biology College of Chemistry Jilin University Changchun 130012 P. R. China

Joint Laboratory of Opto‐Functional Theranostics in Medicine and Chemistry The First Hospital of Jilin University Changchun 130021 P. R. China

Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling School and Hospital of Stomatology Jilin University Changchun 130021 P. R. China

School of Chemistry and Pharmaceutical Engineering Jilin Institute of Chemical Technology Jilin 132022 P. R. China

Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education Institute of Immunology The First Hospital of Jilin University Changchun 130021 P. R. China

Funding

National Key Research and Development Program of China

References (60)

Show source-provided references
1. 10.1073/pnas.171891711510.1073/pnas.1718917115 ↗
2. 10.1038/s41551-019-0494-010.1038/s41551-019-0494-0 ↗
3. 10.1002/anie.20190956010.1002/anie.201909560 ↗
4. 10.1021/jacs.0c0702210.1021/jacs.0c07022 ↗
5. 10.1038/s41565-022-01130-310.1038/s41565-022-01130-3 ↗
6. 10.1038/nnano.2009.29410.1038/nnano.2009.294 ↗
7. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
8. 10.1117/1.JBO.21.12.12600610.1117/1.JBO.21.12.126006 ↗
9. 10.1088/0022-3727/38/15/00410.1088/0022-3727/38/15/004 ↗
10. 10.1038/nphoton.2012.33610.1038/nphoton.2012.336 ↗
11. 10.1038/s41377-021-00628-010.1038/s41377-021-00628-0 ↗
12. 10.1002/anie.20150747310.1002/anie.201507473 ↗
13. 10.1021/jacs.9b1004310.1021/jacs.9b10043 ↗
14. 10.1021/acscentsci.0c0054410.1021/acscentsci.0c00544 ↗
15. 10.1002/adma.20190032110.1002/adma.201900321 ↗
16. 10.1002/anie.20211427310.1002/anie.202114273 ↗
17. 10.1021/jacs.7b1033410.1021/jacs.7b10334 ↗
18. 10.1002/adma.20220664310.1002/adma.202206643 ↗
19. 10.1021/acsnano.2c0861910.1021/acsnano.2c08619 ↗
20. 10.1038/ncomms1526910.1038/ncomms15269 ↗
21. 10.1038/nmat447610.1038/nmat4476 ↗
22. 10.1002/anie.20200704010.1002/anie.202007040 ↗
23. 10.1002/anie.20211743610.1002/anie.202117436 ↗
24. 10.1002/anie.20210264010.1002/anie.202102640 ↗
25. 10.1038/s41467-019-09043-x10.1038/s41467-019-09043-x ↗
26. 10.7150/thno.3359510.7150/thno.33595 ↗
27. 10.1002/anie.20130734610.1002/anie.201307346 ↗
28. 10.1002/adma.20221017910.1002/adma.202210179 ↗
29. 10.1002/anie.20230506210.1002/anie.202305062 ↗
30. 10.1038/s41467-020-16924-z10.1038/s41467-020-16924-z ↗
31. 10.1002/anie.20180122610.1002/anie.201801226 ↗
32. 10.1002/anie.20190418210.1002/anie.201904182 ↗
33. 10.1021/jacs.2c1004110.1021/jacs.2c10041 ↗
34. 10.1021/acs.jmedchem.8b0168210.1021/acs.jmedchem.8b01682 ↗
35. 10.1038/s41557-020-00554-510.1038/s41557-020-00554-5 ↗
36. 10.1002/anie.20170697410.1002/anie.201706974 ↗
37. 10.1021/jacs.9b0519510.1021/jacs.9b05195 ↗
38. 10.1038/s41592-022-01394-610.1038/s41592-022-01394-6 ↗
39. 10.1021/acsabm.8b0060010.1021/acsabm.8b00600 ↗
40. 10.1021/ja962695310.1021/ja9626953 ↗
41. 10.1021/acs.accounts.6b0051710.1021/acs.accounts.6b00517 ↗
42. 10.1002/adma.20220126310.1002/adma.202201263 ↗
43. 10.1021/acs.accounts.0c0073310.1021/acs.accounts.0c00733 ↗
44. 10.1111/php.1353110.1111/php.13531 ↗
45. 10.1021/jacs.8b0440410.1021/jacs.8b04404 ↗
46. 10.1021/ja910088610.1021/ja9100886 ↗
47. 10.1021/jz100830r10.1021/jz100830r ↗
48. 10.1002/idm2.1205010.1002/idm2.12050 ↗
49. 10.1039/D2SC05651H10.1039/D2SC05651H ↗
50. 10.7150/thno.7144310.7150/thno.71443 ↗
51. 10.1038/s41467-022-30304-910.1038/s41467-022-30304-9 ↗
52. 10.7150/thno.4353310.7150/thno.43533 ↗
53. 10.1002/smll.20180161210.1002/smll.201801612 ↗
54. 10.1002/adma.20170419610.1002/adma.201704196 ↗
55. 10.2967/jnumed.114.14958310.2967/jnumed.114.149583 ↗
56. 10.1021/acs.molpharmaceut.6b0101010.1021/acs.molpharmaceut.6b01010 ↗
57. 10.1002/anie.20070493610.1002/anie.200704936 ↗
58. 10.1038/nbt.176410.1038/nbt.1764 ↗
59. 10.1126/scitranslmed.aay071210.1126/scitranslmed.aay0712 ↗
60. 10.1371/journal.pone.013027610.1371/journal.pone.0130276 ↗